9 September 2019

Stichting Katholieke Universiteit (SKU) is going to examine the possibility of the administrative demerger of Radboud University and Radboud university medical center. At present the two act as a single institution in administrative, legal, tax and financial terms, which means they are entirely dependent on each other. The aim is to make both organisations more efficient within an increasingly dynamic and complex environment, and to ensure ongoing oversight in the future. The organisations will keep working with each other in substantive terms based on their own responsibilities.

For the time being both organisations constitute part of Stichting Katholieke Universiteit (SKU). The SKU Board oversees the situation prevailing within Radboud University and Radboud university medical center. Radboud University and Radboud university medical center wish for an increased scope to make their own strategic assessments and to bear responsibility for those assessments themselves. This would yield better opportunities for focused profiling. A new, appropriate organisational structure would also make it possible to acquire more specialist expertise in a supervisory capacity.

Continued collaboration

Stichting Katholieke Universiteit (SKU) and the Executive Boards of Radboud university medical center and Radboud University stress that the organisations will continue to collaborate with each other in substantive terms, despite a different organisational structure. DaniĆ«l Wigboldus, President of the Radboud University Executive Board, says: “Radboud University’s faculty of medicine will remain incorporated within Radboud university medical center.” Paul Smits, Chair of the Radboud university medical center Executive Board, adds: “In addition, we share our origin, which make us distinctive now and will do so in the future.” Both organisations will draw up a common strategic agenda for this purpose, although they will not be responsible for each other across the board within the new organisational structure which is envisaged. Based on their own aspirations and a common strategic agenda, both organisations expect to be able to achieve a greater social impact.

Decision in 2020

During the months ahead a project team established by SKU will examine the type of structure best suited to both organisation’s further operations, how a supervisory structure may be devised, and what the legal, organisational and financial implications would be. Consequently, discussions will be held with all of the parties involved as well as the participational bodies. A final decision is planned for the end of 2020.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Nieuws home

More information


Viola Peulen

hoofd corporate communicatie

(024) 36 67378

Related news items


New insight into the effect of hydroxychloroquine undermines its use in corona

11 June 2020

Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. Raphael Duivenvoorden was interviewed in the program Op1 at NPO1 to elaborate on the findings. It seems unlikely that chloroquine has beneficial effect in corona infections.

read more

Henri Timmers appointed professor of Endocrine Diseases

8 June 2020

Henri Timmers has been appointed professor of Internal Medicine, with a special focus on endocrine diseases, at Radboud University/Radboud university medical center. This appointment became effective on 1 May 2020.

read more

Royal honours for seven Radboud professors

24 April 2020

On Friday 24 April, seven professors from Radboud University and Radboud university medical center received telephone calls from the mayors of their towns informing them that they had been awarded royal honours for their exceptional scientific and social merits.

read more

Study on effect of BCG vaccine on coronavirus infection in the elderly

21 April 2020

Radboud university medical center and UMC Utrecht are working on a joint research project to discover whether the tuberculosis (BCG) vaccine reduces the risk of infection with the coronavirus in people aged 60 or older, or the severity of the symptoms in the event of infection.

read more

Radboudumc researchers publish new insights into COVID-19 Consequences for treatment are now being examined internationally

10 April 2020

Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of Covid-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease.

read more